Induced abortion Pregnancy and Childbirth Abortion
Conditions
Interventions
Misoprostol (0.4 mg) versus placebo tablet three hours before vacuum aspiration. Approximate duration of involvement in the study for each subject is one follow up visit ten days post-treatment.
Sponsors
UNDP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Pregnancy of less than 12 completed weeks 2. Be informed about the study and sign a consent form 3. Agree to return for a follow-up visit five to ten days after surgery
Exclusion criteria
Exclusion criteria: No exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Will evaluate if preoperative treatment with 0.4 mg misoprostol administered vaginally three hours before vacuum aspiration can reduce complications of surgical first trimester abortion. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
Armenia, China, Cuba, Hungary, India, Mongolia, Romania, Slovenia, Viet Nam
Outcome results
None listed